Systematic Review
Copyright ©The Author(s) 2020.
World J Clin Cases. Feb 26, 2020; 8(4): 771-781
Published online Feb 26, 2020. doi: 10.12998/wjcc.v8.i4.771
Table 1 Clinicopathological characteristics of reported lymphoepithelioma-like carcinomas in the upper urinary tract
Case No.Age/genderRegionPresentationSideLocationTumor stageHCCK antigenEBV-statusTreatmentFollow-up in moOutcomeRef.
173/FAsia (Chinese Taipei)HematuriaRightRenal pelvispT2N0M0Pure7NMRNU24NEDChen et al[16], 2018
254/M4 Europe (Spain); The remaining 6 unknownHematuriaNMUreterpT3N1MxPredominant7;20;CKAE1/AE3NegativeRN + Ch39DWDLopez-Beltran et al[15], 2017
362/MHematuriaNMUreterpT1N0MxPure7;20;CKAE1/AE3NegativeRNU55NEDLopez-Beltran et al[15], 2017
462/FHematuriaNMUreterpT2N0MxPredominant7;20;CKAE1/AE3NegativeU18NEDLopez-Beltran et al[15], 2017
580/FHematuriaNMUreterpT3N0MxPure7;20;CKAE1/AE3NegativeRNU39NEDLopez-Beltran et al[15], 2017
676/MHematuriaNMUreterpT3N1M0Predominant7;20;CKAE1/AE3NegativeRNU + Ch29NEDLopez-Beltran et al[15], 2017
761/MHematuriaNMUreterpT1N0MxPure7;20;CKAE1/AE3NegativeU35NEDLopez-Beltran et al[15], 2017
864/MHematuriaNMRenal pelvispT2N0MxPredominant7;20;CKAE1/AE3NegativeRN58NEDLopez-Beltran et al[15], 2017
981/MHematuriaNMRenal pelvispT3N1MxPredominant7;20;CKAE1/AE3NegativeRN+ Ch7DWDLopez-Beltran et al[15], 2017
1085/MHematuriaNMRenal pelvispT3N1MxPredominant7;20;CKAE1/AE3NegativeRN + Ch4DWDLopez-Beltran et al[15], 2017
1181/MHematuriaNMRenal pelvispT3N1M0Predominant7;20;CKAE1/AE3NegativeRN + Ch10DWDLopez-Beltran et al[15], 2017
1265/FAsia (Korea)HematuriaRightRenal pelvisT3N0M0PredominantCytokeratinNegativeRN6NEDAhn et al[17], 2014
1361/MAsia (China)Flank pain; HematuriaLeftRenal pelvisT4N2M0NM7NegativeRN3DWDLiu et al[20], 2014
1475/FEurope (UK)Flank pain; HematuriaRightRenal pelvisT3N1M0Predominant20;AE1/AE3NMRNU6NEDModi et al[14], 2013
1564/MAsia (Chinese Taipei)NauseaRightUreterpT3N0M0Pure7NegativeRNU6NEDWen et al[25], 2012
1676/FEurope (Spain)Recurrent UTILeftUreterT2N0M0Pure7;20;CKAE1/AE3NegativePN+U5NEDVal-Bernal et al[27], 2011
1771/MAmerica (United States)HematuriaRightUreterT2NxMxPure7;20;CKAE1/AE3NegativeRNU5NEDAllend et al[18], 2010
1864/FAmerica (United States)HematuriaLeftUreterT2NxMxPure7;CKAE1/AE3NegativeU24NEDMa et al[21], 2008
1975/FAsia (Japan)Flank pain; HematuriaLeftRenal pelvisT1N1M0PureUnknownNegativeRNU36NEDHaga et al[26], 2007
2075/FAsia (Japan)Flank pain; HematuriaLeftRenal pelvisT3N0M0NM15NegativeRN6NEDYamada et al[11], 2007
2172/FEurope or AmericaIncidental findingNMRenal pelvisT3PredominantAE1/AE3NegativeRN3DWDPerez-Montiel et al[13], 2006
2268/MEurope or AmericaIncidental findingNMRenal pelvisT3FocalAE1/AE3NegativeRN12DWDPerez-Montiel et al[13], 2006
2373/MAsia (Japan)HematuriaRightUreterT2N0MxPureCKAE1/AE3NegativeRNU30NEDTerai et al[24], 2005
2458/MEurope (Spain)HematuriaLeftUreterT3N0M0PureCKAE1/AE3NegativeRNU18NEDRoig et al[23], 2001
2562/FAsia (Chinese Taipei)HematuriaRightUreterT2N0M0PureCKAE1/AE 3NegativeRNU18NEDNg et al[22], 1999
2679/FAustraliaFlank pain; HematuriaRightRenal pelvisT3N0M0NMAE1/AE3NegativeRNU6NEDCohen et al[10], 1999
2770/MAsia (Japan)Flank pain; HematuriaNMRenal pelvisT1N0M0Pure7;20NegativeRNU + RT72NEDFukunaga et al[9], 1998
2875/MAmerica (United States)HematuriaRightUreterT3N0M0Pure7;20NegativeU12NEDChalik et al[19], 1998
Table 2 Summary of clinicopathological patient characteristics
Variablen (%), median (range)
Age in yr72 (54-85)
Gender
Female12 (42.9)
Male16 (57.1)
Presentation
Hematuria19 (67.9)
Pain2 (7.1)
Hematuria and flank pain3 (10.7)
Nausea1 (3.6)
Recurrent UTI1 (3.6)
Incidental finding2 (7.1)
Side
Left6 (21.4)
Right9 (32.2)
NM13 (46.4)
Location
Renal pelvis14 (51)
Ureter14 (50)
HC
Pure14 (50)
Predominant10 (35.7)
Focal1 (3.6)
Unknown3 (10.7)
Tumor stage
T14 (14.2)
T28 (28.6)
T315 (53.6)
T41 (3.6)
Treatment strategy
RNU-based therapy13 (46.4)
Non RNU-based therapy15 (53.6)
Follow-up in mo15 (3-72)
Outcome
NED21 (75)
DWD7 (25)